Oxford

[wildbarnet]

Vaccine 70% I could cry is this good or bad ?

I suppose that using a British vaccine rather than one from abroad would reduce the carbon footprint. Especially when they have to be kept at such low temperatures.

Unfortunately the first doses of any approved Oxford Vaccine that are used in GB would be made in Belgium apparently.

I think it's really key that the Oxford trials regularly tested participants but Pfizer only tested participants with symptoms, this means the effect of the Pfizer vaccine on asymptomatic people with covid and people with unusual symptoms of it are unknown.
To have a vaccine with 70% effectiveness that seems able to prevent serious disease at this point is absolutely amazing, to have the Pfizer vaccine too is quite an incredible feat of science.

I'm really hoping it meets expectations, because for much of the world it's the best hope of a way out of the pandemic, Pfizer just can't be rolled out globally at this point in time.

I feel incredibly grateful to the volunteers in the trials.

Its very clear that certain sectors of the US are dissing the cheaper Astra Zeneca vaccine. Wall Street and investors are looking to make a killing. They've been criticising Oxford's vaccine for months, way before even the first data on monkeys was released months ago.

You are sadly correct.

@notevenat20

Is there any similar data available for the Pfizer vaccine? E.g. the age of people in the trial etc

mobile.twitter.com/fperrywilson/status/1336296300858503168

The Indian authorities have declined to issue an accelerated approval of the Oxford vaccine:

“British drugmaker AstraZeneca is already running behind early competitors in the hunt for a Covid-19 vaccine with interim data that have received less-than-stellar feedback. With those data in hand, India has said “no thanks” to an early approval for the shot, potentially setting the stage for even more setbacks.

On Tuesday, Indian regulators refused to grant AstraZeneca’s adenovirus-based Covid-19 vaccine an emergency use authorization based on a dearth of adequate safety and efficacy data, Reuters reported, citing local broadcaster NDTV.”

endpts.com/astrazenecas-vaccine-hit-its-first-roadblock-with-indian-regulators-will-lingering-doubts-derail-its-plans-elsewhere/

^ Correction — it seems they haven’t rejected it just yet, they have requested more data.

www.thechronicleherald.ca/news/world/india-denies-it-rejected-emergency-astrazeneca-shot-approval-529149/

As they should, given the other potential issue they have with an rumoured organochlorine poisoning event they must be careful - especially given the anaphylaxis coming from Pfizer

I have said it before forthrblueskies be careful your clear bias against this vaccine doesn’t muddy the bits that you say which should be is tended to

@Quartz2208

As they should, given the other potential issue they have with an rumoured organochlorine poisoning event they must be careful - especially given the anaphylaxis coming from Pfizer

I have said it before forthrblueskies be careful your clear bias against this vaccine doesn’t muddy the bits that you say which should be is tended to

You are mistaken in assuming I have a personal bias against the Oxford vaccine. I am critical of it, yes, only because I have read an abundance of concerning points raised by experts (and not just ones in the States).

I’m not here to talk up Pfizer or whatnot, despite your continual insinuations. Have you considered you might have a bias based on your own nationality/country of residence?

This is the last time I will be replying to you, not here for a fight.

Incidentally the Indian decision is being reported as a “no pending more data”. It seems they are keen to see the outcome of the MHRA evaluation and a bunch of other requested data first.

Given the publicity around the potential adverse event in India this is not a huge surprise — curious that event and the legal drama around it haven’t made it to the press here.

The Guardian has reported this with regard to the vaccine in US:-

www.theguardian.com/business/2020/dec/09/covid-vaccines-us-regulator-sceptical-over-astrazeneca-model

And there was something about India and Astra Zeneca in The Independent last week. So hardly not reporting negative stuff about AZ.

Sounds like regulatory bodies around the world are doing there stuff 👍.

Their stuff

Correction — it seems they haven’t rejected it just yet, they have requested more data

This must have been disappointing for you to realise. Still, cling on to that 'just yet eh?